EX-31.1 4 exhibit311.htm EX-31.1 exhibit311
 
 
 
Exhibit 31.1
CERTIFICATION OF PRINCIPAL
 
EXECUTIVE OFFICER PURSUANT TO
 
RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES
 
EXCHANGE ACT OF 1934,
 
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY
 
ACT OF 2002
I, Mei Mei Hu, certify that:
1.
 
I have reviewed this Annual Report on Form 10-K of Vaxxinity,
 
Inc.;
2.
 
Based on my knowledge, this report does not contain any untrue
 
statement of a material fact or omit to state a
material fact necessary to make the statements made, in light of the circumstances
 
under which such statements were
made, not misleading with respect to the period covered by this report;
3.
 
Based on my knowledge, the financial statements, and other financial
 
information included in this report, fairly
present in all material respects the financial condition, results of operations
 
and cash flows of the registrant as of, and for,
the periods presented in this report;
4.
 
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure
controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e))
 
for the registrant and have:
(a)
 
Designed such disclosure controls and procedures, or caused such
 
disclosure controls and procedures to
be designed under our supervision, to ensure that material information
 
relating to the registrant, including its
consolidated subsidiaries, is made known to us by others within
 
those entities, particularly during the period in
which this report is being prepared;
 
(b)
 
[Paragraph omitted pursuant to SEC Release Nos. 33-8238/34-47986
 
and 33-8392/34-49313];
(c)
 
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this
report our conclusions about the effectiveness of the disclosure controls and procedures,
 
as of the end of the
period covered by this report based on such evaluation; and
(d)
 
Disclosed in this report any change in the registrant’s internal control over financial reporting that
occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an
annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal
control over financial reporting; and
5.
 
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal
control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors
(or persons performing the equivalent functions):
(a)
 
All significant deficiencies and material weaknesses in the design or
 
operation of internal control over
financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process,
summarize and report financial information; and
(b)
 
Any fraud, whether or not material, that involves management or other employees
 
who have a significant
role in the registrant’s internal control over financial reporting.
 
Date: March 24, 2022
 
By:
 
/s/ Mei Mei Hu
 
 
Mei Mei Hu
 
President and Chief Executive Officer
(Principal Executive Officer)